ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,70
-0,68%
Dow Jones
40 211,72
0,53%
DAX
18 522,42
-0,42%
Brent Oil
83,58
-0,90%
Bitcoin
63 571,10
-1,97%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
14/05/202014h00PR Newswire (US)U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for...NASDAQ:PTLAPortola Pharmaceuticals Inc
11/05/202022h12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
11/05/202022h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
11/05/202014h00PR Newswire (US)Portola Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
08/05/202015h58Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/05/202023h31Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/05/202023h19Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PTLAPortola Pharmaceuticals Inc
06/05/202002h02PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Portola Pharmaceuticals, Inc.NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202022h02PR Newswire (US)Portola Pharmaceuticals Cancels First Quarter 2020 Financial Results Webcast and Conference Call Following Agreement to be Ac...NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202021h10PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Portola Pharmaceuticals, Inc.NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202020h23PR Newswire (US)Moore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law FirmNASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202018h39PR Newswire (US)Portola Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Portola Pharmaceuticals, Inc....NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202016h48PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Portola Pharmaceuticals, Inc. has obtained a Fair Price in its...NASDAQ:PTLAPortola Pharmaceuticals Inc
01/05/202022h23PR Newswire (US)Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:PTLAPortola Pharmaceuticals Inc
23/04/202022h21PR Newswire (US)Portola Pharmaceuticals to Announce First Quarter 2020 Financial Results on Monday, May 11, 2020NASDAQ:PTLAPortola Pharmaceuticals Inc
20/04/202023h06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
20/04/202023h05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
09/04/202012h08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/04/202014h00PR Newswire (US)Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid ...NASDAQ:PTLAPortola Pharmaceuticals Inc
18/03/202021h11PR Newswire (US)Portola Pharmaceuticals Announces Proactive Steps Supporting Public Health Efforts to Combat Coronavirus (COVID-19)NASDAQ:PTLAPortola Pharmaceuticals Inc
16/03/202013h05PR Newswire (US)Portola Pharmaceuticals Announces Results Demonstrating Andexxa® was Associated with Lowest Rate of Mortality in Patients wi...NASDAQ:PTLAPortola Pharmaceuticals Inc
05/03/202014h30PR Newswire (US)New Data Demonstrates Andexxa® Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/03/202000h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/03/202021h59Business WireShareholder Alert: Robbins LLP Announces Another Complaint Filed Against Portola Pharmaceuticals, Inc. (PTLA)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/03/202017h27Business WireFederman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Portola ...NASDAQ:PTLAPortola Pharmaceuticals Inc
28/02/202022h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
28/02/202001h52Business WirePTLA INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors in Portola Pharmaceuticals, Inc. of a Filing Deadline in ...NASDAQ:PTLAPortola Pharmaceuticals Inc
26/02/202022h01PR Newswire (US)Portola Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
24/02/202014h00PR Newswire (US)Portola Pharmaceuticals to Participate in Two Upcoming Investor ConferencesNASDAQ:PTLAPortola Pharmaceuticals Inc
12/02/202014h00PR Newswire (US)Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020NASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

BIT
P22SO0
NLBNPIT22SO0 20241220 800
NASDAQ
LIFWW
MSP Recovery
LSE
0JX9
Marimekko Oyj
NASDAQ
CPARW
Catalyst Partners Acquis...
USOTC
THMG
Thunder Mountain Gold (QB)
LSE
0OG6
Seche Environnement
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés